MAPT and Alzheimer disease: Similarly, miR-483-5p is recently reported to regulate ERK1 and ERK2 kinases at both mRNA and protein levels, resulting in reduced phosphorylation of Tau protein associated with Tau neurofibrillary pathology in AD.